Key Insights

Highlights

Success Rate

92% trial completion (above average)

Published Results

175 trials with published results (25%)

Research Maturity

472 completed trials (68% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

6.2%

43 terminated out of 693 trials

Success Rate

91.7%

+5.1% vs benchmark

Late-Stage Pipeline

14%

98 trials in Phase 3/4

Results Transparency

37%

175 of 472 completed with results

Key Signals

175 with results92% success43 terminated

Data Visualizations

Phase Distribution

566Total
Not Applicable (265)
Early P 1 (10)
P 1 (107)
P 2 (86)
P 3 (51)
P 4 (47)

Trial Status

Completed472
Recruiting55
Unknown51
Terminated43
Not Yet Recruiting31
Active Not Recruiting21

Trial Success Rate

91.7%

Benchmark: 86.5%

Based on 472 completed trials

Clinical Trials (693)

Showing 20 of 20 trials
NCT07099482Not ApplicableNot Yet Recruiting

"Ultrasound-Enhanced Propolis Therapy for Healing Diabetic Foot Wounds"

NCT03734107Not ApplicableCompletedPrimary

Improving Health Communication During the Transition From Pediatric to Adult Diabetes Care

NCT03859401Not ApplicableCompletedPrimary

Exercise-Induced Hypoglycemia Prevention in Adults With Type 1 Diabetes Using an Artificial Pancreas

NCT07224321Phase 2RecruitingPrimary

INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes

NCT07568028RecruitingPrimary

Examining Multilevel Factors Affecting Participation in Physical Activity Among Adolescents With Type 1 Diabetes Using the Socio-Ecological Model

NCT06919354Phase 1Recruiting

A Study of GNTI-122 in Adults Recently Diagnosed With T1D

NCT06783309Phase 1RecruitingPrimary

CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

NCT07561086Not ApplicableCompletedPrimary

Innovative Insulin Injection Sites Map to Minimize Lipohypertrophy Risk

NCT07177404Completed

Choices and Experiences Around Closed-loop Therapy in Type 1 Diabetes

NCT07425912CompletedPrimary

Real-World Evaluation of TouchCare Nano in Pediatric Type 1 Diabetes

NCT07088068Phase 3RecruitingPrimary

A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

NCT07548996Phase 2RecruitingPrimary

Open-Label Study of Dimethyl Fumarate in Adults With Type 1 Diabetes

NCT04590872Phase 1Active Not RecruitingPrimary

An Immunotherapy Vaccine (PIpepTolDC) for the Treatment of Patients With Type 1 Diabetes

NCT07490964Not Yet RecruitingPrimary

Polycystic Ovary Syndrome in Type 1 Diabetes

NCT06704672Not ApplicableRecruitingPrimary

Clinical Study to Evaluate the Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in Range Compared With Self-Monitoring of Blood Glucose in Participants With Type 1 and Type 2 Diabetes Mellitus

NCT05018585Phase 3Active Not RecruitingPrimary

A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes

NCT07527676Not Yet RecruitingPrimary

Hypoglycemia Fear Affect Autonomic Function, Physical Activity, and Exercise Capacity in Type I Diabetes

NCT06791291Phase 2RecruitingPrimary

Efficacy and Safety of Teplizumab in Japanese Participants With Stage 2 Type 1 Diabetes

NCT06474598Phase 2RecruitingPrimary

An Adaptive Design Study of MTX228

NCT07296276Not ApplicableRecruitingPrimary

Accuracy and Precision of the Continuous Glucose Monitoring System 'CareSens Air 3' in Adult Patients With T1DM

Scroll to load more

Research Network

Activity Timeline